Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35)
Autor: | Paolo Golino, Maria Giovanna Russo, Gianpiero Gaio, Berardo Sarubbi, Mario Giordano, Giuseppe Santoro, Maria Teresa Palladino |
---|---|
Přispěvatelé: | Giordano, Mario, Gaio, Gianpiero, Santoro, Giuseppe, Palladino, Maria Teresa, Sarubbi, Berardo, Golino, Paolo, Russo, Maria Giovanna |
Rok vydání: | 2019 |
Předmět: |
Adult
Male Cardiac Catheterization Septal Occluder Device Group ii Foramen Ovale Patent 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Amplatzer Septal Occluder Device medicine Humans Septal Occluder Amplatzer PFO Occluder device 030212 general & internal medicine Ischemic cerebral event business.industry Equipment Design Anatomy Middle Aged medicine.disease Amplatzer Septal Occluder device Patent foramen ovale Treatment Outcome Female Cardiology and Cardiovascular Medicine business Echocardiography Transesophageal Shunt (electrical) Follow-Up Studies |
Zdroj: | International Journal of Cardiology. 279:47-50 |
ISSN: | 0167-5273 |
DOI: | 10.1016/j.ijcard.2018.10.053 |
Popis: | Background: Patent foramen ovale (PFO) closure after a cryptogenic cerebral ischemic event is a routinely procedure. The most used device is Amplatzer™ PFO Occluder 25 mm, but PFOs with complex anatomy require larger device for closure. We compared Amplatzer™ Septal Occluder (ASO) device versus Amplatzer™ PFO Occluder 30 or 35 mm (A-PFO 30/35) about the safety of procedure and the presence of residual shunt during the follow-up. Methods: From June 2002 to July 2016, 355 patients (pts) with PFO undergone closure at our institution. Among these ones, 70 pts (19.7%) had a PFO with complex anatomy and a single device with greater diameter was implanted. In these cases, the following devices were used: Gore® Septal Occluder (GSO) in 4 pts; ASO device in 33 pts (group I) and A-PFO 30/35 in 33 pts (group II). Patients treated with GSO device were excluded by our analysis. Results: Comparing group I and group II, there weren't complications during the procedures. Two patients of group II were lost at follow-up. At last follow-up, 1 pt of group I (3%) and 10 pts of group II (32.3%) had a residual shunt (p < 0.01). 7 of 10 pts of group II and the only 1 of group I with residual shunt underwent a complete closure by Amplatzer™ Vascular Plug (AVP) devices. Conclusions: ASO devices and A-PFO 30/35 devices are both safe to close complex PFO; but A-PFO 30/35 is associated with a more incidence of residual shunt. |
Databáze: | OpenAIRE |
Externí odkaz: |